Article: AMGEN SEEKS TO HIKE ENBREL PRODUCTION.(Business)

Byline: Evan Pondel Staff Writer

THOUSAND OAKS - Amgen Inc. said Friday it applied for regulatory approval of an Enbrel manufacturing facility in Rhode Island - a crucial step to alleviate shortages of the arthritis drug.

With about 23,000 patients unable to treat their rheumatoid arthritis through a prescription of Enbrel, Amgen is attempting to quash the problem. Pending approval from the Food and Drug Administration, Amgen anticipates increasing its Enbrel production by the first quarter of 2003.

``But right now we are not activating new patients on Enbrel because of the current situation,'' said Rebecca Hamm, spokeswoman for the Thousand ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!